BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 32211939)

  • 1. Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy.
    Schmitt D; Blanck O; Gauer T; Fix MK; Brunner TB; Fleckenstein J; Loutfi-Krauss B; Manser P; Werner R; Wilhelm ML; Baus WW; Moustakis C
    Strahlenther Onkol; 2020 May; 196(5):421-443. PubMed ID: 32211939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
    Guckenberger M; Baus WW; Blanck O; Combs SE; Debus J; Engenhart-Cabillic R; Gauer T; Grosu AL; Schmitt D; Tanadini-Lang S; Moustakis C
    Strahlenther Onkol; 2020 May; 196(5):417-420. PubMed ID: 32211940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
    Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
    Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy".
    Putz F; Bock M; Schmitt D; Bert C; Blanck O; Ruge MI; Hattingen E; Karger CP; Fietkau R; Grigo J; Schmidt MA; Bäuerle T; Wittig A
    Strahlenther Onkol; 2024 Jan; 200(1):1-18. PubMed ID: 38163834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.
    Wilke L; Andratschke N; Blanck O; Brunner TB; Combs SE; Grosu AL; Moustakis C; Schmitt D; Baus WW; Guckenberger M
    Strahlenther Onkol; 2019 Mar; 195(3):193-198. PubMed ID: 30649567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
    Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
    Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
    Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
    Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.
    Guckenberger M; Andratschke N; Alheit H; Holy R; Moustakis C; Nestle U; Sauer O;
    Strahlenther Onkol; 2014 Jan; 190(1):26-33. PubMed ID: 24052011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.
    Sterzing F; Brunner TB; Ernst I; Baus WW; Greve B; Herfarth K; Guckenberger M
    Strahlenther Onkol; 2014 Oct; 190(10):872-81. PubMed ID: 25091267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans.
    James S; Al-Basheer A; Elder E; Huh C; Ackerman C; Barrett J; Hamilton R; Mostafaei F
    J Appl Clin Med Phys; 2023 Aug; 24(8):e14009. PubMed ID: 37158727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
    Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise film dosimetry for stereotactic radiosurgery and stereotactic body radiotherapy quality assurance using Gafchromic™ EBT3 films.
    Wen N; Lu S; Kim J; Qin Y; Huang Y; Zhao B; Liu C; Chetty IJ
    Radiat Oncol; 2016 Oct; 11(1):132. PubMed ID: 27716323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial.
    Zabel-du Bois A; Milker-Zabel S; Henzel M; Popp W; Debus J; Sack H; Engenhart-Cabillic R
    Strahlenther Onkol; 2012 Sep; 188(9):769-76. PubMed ID: 22847518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM.
    Conde-Moreno AJ; Zucca Aparicio D; Pérez-Calatayud MJ; López-Campos F; Celada Álvarez F; Rubio Rodríguez C; Fernández-Letón P; Gómez-Caamaño A; Contreras Martínez J
    Clin Transl Oncol; 2021 Jul; 23(7):1281-1291. PubMed ID: 33565008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A halo-ring technique for fractionated stereotactic radiotherapy.
    Clark BG; Podgorsak EB; Souhami L; Olivier A; Sixel KE; Caron JL
    Br J Radiol; 1993 Jun; 66(786):522-7. PubMed ID: 8330137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
    Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
    Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-centre experience of stereotactic radiosurgery and fractionated stereotactic radiotherapy for prolactinomas with the linear accelerator.
    Wilson PJ; Williams JR; Smee RI
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):371-8. PubMed ID: 25410143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery and radiotherapy for acoustic neuromas.
    Kalogeridi MA; Kougioumtzopoulou A; Zygogianni A; Kouloulias V
    Neurosurg Rev; 2020 Jun; 43(3):941-949. PubMed ID: 30982152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.